Items Tagged ‘biopsy’
November 12, 2020 · Leave a Comment
New research shows markers in donor kidneys that could reduce risks
By Advancing the Science contributor 
By Jay Furst The donation of a kidney to a person in need of a transplant is one of the most profound gifts a person can offer. The process for living kidney donors is safe, and, at Mayo Clinic, which has one of the largest living-donor kidney transplant programs in the U.S., the process is […]
View full entry Comment on this
Tags: Andrew Rule, biopsy, Center for Clinical and Translational Science, clinical research, kidney disease, kidney transplant, living donor, Massini Merzkani, Mayo Clinic Proceedings, Naim Issa
January 30, 2020 · Leave a Comment
A breakthrough in distinguishing benign adrenal tumors from cancerous ones
By Advancing the Science contributor
By Christoph Bahn Approximately 80 million CT scans are performed in the United States every year. Adrenal tumors are found incidentally in about 5% of these scans. Most of these tumors will turn out to be benign, but a small fraction will be adrenal cortical carcinoma, a type of cancer with high mortality and frequent recurrence; even for […]
View full entry Comment on this
Tags: adrenal tumors, biomarkers, biopsy, cancer, clinical research, CT, endocrine cancer, endocrinology, epidemiology, hormones, Irina Bancos, Mayo Clinic Laboratories
December 30, 2019 · Leave a Comment
Research highlights from Florida – fruitful in 2019
By Advancing the Science contributor
Florida sunshine doesn’t just contribute to big, juicy oranges. In 2019, Florida was a hotbed of growth for Mayo Clinic Research, with 11.8% more funding leading to new capabilities such as ex vivo perfusion for lungs – leading to more available for transplant, and carbon ion therapy for cancer – currently not available to patients in the U.S. Read on for more on these and other practice transforming activities.
View full entry Comment on this
Tags: artificial intelligence, biopsy, breast cancer, cancer, cancer vaccine, carbon ion therapy, Center for Individualized Medicine, clinical trials, ex vivo lung perfusion, immunology, Keith Knutson, lung cancer